Home › NDC Lookup › RxCUI directory › RxCUI 797452

Erythromycin 20 MG/ML Medicated Pad — RxCUI 797452

RxNorm drug concept · Semantic clinical drug
RxCUI 797452 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI797452
Official nameErythromycin 20 MG/ML Medicated Pad
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aserythromycin 2 % Medicated Pad
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,090 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Erythromycin Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's used to treat bacterial infections on the surface of your eye — the conjunctiva (the clear membrane over the white part) and the cornea (the clear front surface). It's also us...
  • What exactly does this eye ointment treat?
  • Gently pull your lower eyelid down to create a small pocket, then squeeze a ribbon of ointment — about 1 cm, roughly the size of a grain of rice — into that pocket. Blink a few tim...
  • How do I apply the ointment without making a mess?
📖 Read our full Erythromycin Ophthalmic guide →

🕸️ Concept Web — How Erythromycin 20 MG/ML Medicated Pad Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Erythromycin 20 MG/ML Medicated Pad RxCUI 797452

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Erythromycin 4053
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Emcin Clear 605264
    • Ery 798130
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Erythromycin Medicated Pad 797451
    • Erythromycin Medicated Pad or Tape 1164501
    • Erythromycin Topical Product 1164507
    • Erythromycin Medicated Pad [Emcin Clear] 798114
    • Erythromycin Medicated Pad [Ery] 798132
    • Emcin Clear Medicated Pad or Tape 1175297
    • Emcin Clear Topical Product 1295800
    • Ery Medicated Pad or Tape 1168948
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Erythromycin 20 MG/ML 329730
    • Erythromycin 20 MG/ML Medicated Pad [Emcin Clear] 798115
    • Erythromycin 20 MG/ML Medicated Pad [Ery] 798133
    • Erythromycin 20 MG/ML [Emcin Clear] 798113
    • Erythromycin 20 MG/ML [Ery] 798131

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Erythromycin 20 MG/ML SCDC · 329730
  • Erythromycin Medicated Pad SCDF · 797451
  • Erythromycin Medicated Pad or Tape SCDG · 1164501
  • Erythromycin Topical Product SCDG · 1164507

Brand-Name Concepts

  • Erythromycin 20 MG/ML Medicated Pad [Ery] SBD · 798133
  • Erythromycin 20 MG/ML Medicated Pad [Emcin Clear] SBD · 798115
  • Erythromycin 20 MG/ML [Emcin Clear] SBDC · 798113
  • Erythromycin 20 MG/ML [Ery] SBDC · 798131
  • Erythromycin Medicated Pad [Emcin Clear] SBDF · 798114
  • Erythromycin Medicated Pad [Ery] SBDF · 798132
  • Emcin Clear Medicated Pad or Tape SBDG · 1175297
  • Emcin Clear Topical Product SBDG · 1295800
  • Ery Medicated Pad or Tape SBDG · 1168948
  • Ery Topical Product SBDG · 1296321

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 797452 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
45802-0962-72 60 APPLICATOR in 1 JAR (45802-962-72) / .8 mL in 1 APPLICAT... Ery Padagis Israel Pharmaceuticals Ltd 2008-07-07
63629-8648-01 60 APPLICATOR in 1 JAR (63629-8648-1) / .8 mL in 1 APPLICAT... Ery Bryant Ranch Prepack 2008-07-07
72162-1443-06 60 APPLICATOR in 1 JAR (72162-1443-6) / .8 mL in 1 APPLICAT... Ery Bryant Ranch Prepack 2024-12-24
Observed labelers: Bryant Ranch Prepack (2) · Padagis Israel Pharmaceuticals Ltd (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$1.2380
Range $1.2380–$1.2380 · middle 50% $1.2380–$1.2380 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.